We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pin Site Infection Prevention for Open Tibial Fracture

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01017094
First Posted: November 20, 2009
Last Update Posted: November 20, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Prince of Songkla University
  Purpose

This study aimed to compare the efficacy of pin-tract infection prevention between silversulfadiazine and dry dressing.

Methods: 30 patients with an open tibial fracture admitted to Songklanagarind hospital from September 2007 to June 2008 and treated by emergency debridement and external fixation were randomized into two groups, one treated with silversulfadiazine for infection prophylaxis (15) and a control group treated with dry dressing only (15). All patients were followed until the external fixator was removed. Pin-site infections were assessed and graded at each follow-up visit by an orthopaedist blinded to the mode of treatment. A culture from the pin site was done if an infection occurred.


Condition Intervention Phase
Tibial Fracture Drug: silversulfadiazine Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Can Silversulfadiazine Prevent Pin-site Infection in Open Tibial Fracture?: A Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Prince of Songkla University:

Primary Outcome Measures:
  • incidence of pin site infection [ Time Frame: 2 years ]

Secondary Outcome Measures:
  • type of organism [ Time Frame: 2 years ]
  • severity of pin site infection [ Time Frame: 2 years ]

Enrollment: 30
Study Start Date: September 2007
Study Completion Date: November 2009
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: dry dressing
local application
Drug: silversulfadiazine
apply once a day

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 60 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Open tibial fracture treated with external fixator age between 15-60 years

Exclusion Criteria:

  • Immunocompromised patients (diabetes, HIV or malignancy)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01017094


Locations
Thailand
Prince of Songkla University
Hat Yai, Songkhla, Thailand, 90110
Sponsors and Collaborators
Prince of Songkla University
Investigators
Principal Investigator: Boonsin Tangtrakulwanich, MD.,Ph.D Faculty of Medicine, Prince of Songkla University
  More Information

Responsible Party: Secretariate,Department of Orthopaedic Surgery, Faculty of Medicine, Prince of Songkla University
ClinicalTrials.gov Identifier: NCT01017094     History of Changes
Other Study ID Numbers: EC 50/369-006
First Submitted: November 17, 2009
First Posted: November 20, 2009
Last Update Posted: November 20, 2009
Last Verified: November 2009

Keywords provided by Prince of Songkla University:
Pin-site infection
silversulfadiazine
open fracture
open tibial fracture underwent external fixator

Additional relevant MeSH terms:
Infection
Fractures, Bone
Tibial Fractures
Wounds and Injuries
Leg Injuries
Silver Sulfadiazine
Anti-Infective Agents, Local
Anti-Infective Agents